Forerunner Pharma Research Co., Ltd.
Records under this name other than patents Forerunner Pharma Research Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Forerunner Pharma Research Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,192,740 | Pharmaceutical Composition Comprising ANTI-GRP78 Antibody as Active Ingredient now held by Chugai Seiyaku Kabushiki Kaisha In force · High confidence | In force | High confidence | |
| US 9,017,684 | Diagnosis and Treatment of Cancer Using Anti-Ereg Antibody now held by Chugai Seiyaku Kabushiki Kaisha In force · High confidence | In force | High confidence | |
| US 8,546,546 | Anti-Muc 17 Antibody now held by Chugai Seiyaku Kabushiki Kaisha In force · High confidence | In force | High confidence | |
| US 9,274,119 | ANTI-CLDN6 Antibody now held by Chugai Seiyaku Kabushiki Kaisha In force · High confidence | In force | High confidence | |
| US 8,680,243 | Diagnosis and Treatment of Cancer Using ANTI-GPR49 Antibody now held by Chugai Seiyaku Kabushiki Kaisha In force · High confidence | In force | High confidence | |
| US 9,139,647 | Diagnosis and Treatment of Cancer Using ANTI-TM4SF20 Antibody now held by Chugai Seiyaku Kabushiki Kaisha In force · High confidence | In force | High confidence | |
| US 8,946,385 | Chimeric Fc-gamma Receptor and Method for Determination of ADCC Activity by Using the Receptor now held by Chugai Seiyaku Kabushiki Kaisha In force · High confidence | In force | High confidence | |
| US 9,127,071 | ANTI-DLL3 Antibody now held by Chugai Seiyaku Kabushiki Kaisha In force · High confidence | In force | High confidence | |
| US 9,079,957 | Diagnosis and Treatment of Cancer Using ANTI-TMPRSS11E Antibody now held by Chugai Seiyaku Kabushiki Kaisha In force · High confidence | In force | High confidence | |
| US 8,846,870 | ANTI-HS6ST2 Antibodies and Uses Thereof now held by Chugai Seiyaku Kabushiki Kaisha Lapsed on the fee record Ended Sep 30, 2026 · High confidence | Lapsed on the fee record | Ended Sep 30, 2026 | High confidence |